BRCA2 and neoplasm: Tissue NGS (Tempus xT 648 gene panel) was obtained in week 81, revealing a BRCA2 copy number loss (unknown whether biallelic or monoallelic), TP54 frameshift mutation, RB1 and TOP2A mutations, with a high tumor mutation burden (TMB) of 10 m/MB.